AbbVie Oy
Osakeyhtiö (oy) · Espoo, Finland · LEI 549300IFW5ZKUU3MX187
LEI lapsed
Summary
AbbVie Oy is registered in Finland and entered in the “Business Information System (YTJ)” under number 2470310-6. Its legal form is Osakeyhtiö (oy) – limited company (Finland). According to GLEIF, its ultimate parent is ABBVIE INC. (United States), which is also its direct parent. That group has 64 subsidiaries with LEIs in 37 countries, 1 of them in Finland. The LEI was first issued on 6 Jun 2018 and the record was last updated on 9 Aug 2023. It has lapsed: renewal was due by 5 Jun 2019. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 5 Jun 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2017, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 9 Aug 2023.
Company details
| Legal form | Osakeyhtiö (oy) limited company (Finland) |
|---|---|
| Register | Business Information System (YTJ) · Register website |
| Registration number | 2470310-6 |
| Registration authority | Finnish Patent and Registration Office |
| Jurisdiction | Finland |
| Registered address | Pihatörmä 1 B, 02240 Espoo, Finland |
| Category | company or other legal entity |
| Status | active |
| LEI | 549300IFW5ZKUU3MX187 |
| LEI status | lapsed |
| LEI first issued | 6 Jun 2018 |
| LEI record last updated | 9 Aug 2023 |
| Next LEI renewal | 5 Jun 2019 |
| Corroboration of the LEI record | fully corroborated |
Group membership
AbbVie Oy this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | ABBVIE INC. | ABBVIE INC. |
| Accounting period | 1 Jan 2017 to 31 Dec 2017 | 1 Jan 2017 to 31 Dec 2017 |
| Evidence | supporting documents | supporting documents |
| Corroboration | partly corroborated | partly corroborated |
| Relationship start | 5 Jun 2018 | 5 Jun 2018 |
| Recorded at GLEIF since | 6 Jun 2018 | 6 Jun 2018 |
| Last updated | 9 Aug 2023 | 9 Aug 2023 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (59)
- AbbVie A/S Denmark lapsed
- AbbVie AG Switzerland lapsed
- AbbVie AS Norway lapsed
- AbbVie B.V. Netherlands lapsed
- AbbVie Bahamas Ltd. Bahamas lapsed
- AbbVie Biopharmaceuticals GmbH Switzerland
- ABBVIE BIOTECHNOLOGY LTD Bermuda
- AbbVie Central Finance B.V. Netherlands
- AbbVie Corporation Canada
- ABBVIE D.O.O. Slovenia lapsed
- AbbVie Deutschland GmbH And Co. KG Germany lapsed
- Abbvie Endocrine Inc. United States lapsed
Other names
- WCA Pharmaceuticals Oy · previous name